- Home
- RPRX vs PINS Comparison
RPRX vs PINS Comparison
Compare RPRX & PINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | PINS |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 17.7B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RPRX | PINS |
|---|---|---|
| Price | $41.24 | $27.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 30 |
| Target Price | ★ $45.75 | $38.72 |
| AVG Volume (30 Days) | 3.4M | ★ 16.9M |
| Earning Date | 02-10-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.17% | N/A |
| EPS Growth | N/A | ★ 824.42 |
| EPS | 1.75 | ★ 2.88 |
| Revenue | $2,349,844,000.00 | ★ $4,056,550,000.00 |
| Revenue This Year | $37.66 | $18.43 |
| Revenue Next Year | $2.34 | $14.20 |
| P/E Ratio | $23.21 | ★ $9.40 |
| Revenue Growth | 3.70 | ★ 16.79 |
| 52 Week Low | $25.40 | $23.68 |
| 52 Week High | $41.24 | $40.90 |
Technical Indicators
Market Signals| Indicator | RPRX | PINS |
|---|---|---|
| Relative Strength Index (RSI) | 70.38 | 58.47 |
| Support Level | $38.29 | $25.70 |
| Resistance Level | $39.46 | $26.97 |
| Average True Range (ATR) | 0.64 | 0.59 |
| MACD | 0.21 | 0.23 |
| Stochastic Oscillator | 97.91 | 90.52 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PINS Pinterest Inc.
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.